Patent foramen ovale after cryptogenic stroke: When is it justifiable to close it?
Open Access
- 1 September 2018
- journal article
- editorial
- Published by Elsevier BV in International Journal of Cardiology
- Vol. 266, 81-82
- https://doi.org/10.1016/j.ijcard.2018.04.110
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Net clinical benefit of patent foramen ovale closure in patients with cryptogenic stroke: Meta-analysis and meta-regression of randomized trialsInternational Journal of Cardiology, 2018
- Cryptogenic Stroke and Patent Foramen OvaleJournal of the American College of Cardiology, 2018
- Identification and Quantification of Patent Foramen Ovale–Mediated ShuntsInterventional Cardiology Clinics, 2017
- Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic StrokeThe New England Journal of Medicine, 2017
- Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after StrokeThe New England Journal of Medicine, 2017
- Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after StrokeThe New England Journal of Medicine, 2017
- Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic StrokeThe New England Journal of Medicine, 2013
- Percutaneous Closure of Patent Foramen Ovale in Cryptogenic EmbolismThe New England Journal of Medicine, 2013
- Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen OvaleThe New England Journal of Medicine, 2012
- Incidence and Size of Patent Foramen Ovale During the First 10 Decades of Life: An Autopsy Study of 965 Normal HeartsMayo Clinic Proceedings, 1984